Author:
Matsumura Mai,Okudela Koji,Kojima Yoko,Umeda Shigeaki,Tateishi Yoko,Sekine Akimasa,Arai Hiromasa,Woo Tetsukan,Tajiri Michihiko,Ohashi Kenichi
Funder
Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan)
Smoking Research Foundation (Tokyo, Japan)
Publisher
Public Library of Science (PLoS)
Reference35 articles.
1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;M Soda;Nature,2007
2. RET, ROS1 and ALK fusions in lung cancer;K Takeuchi;Nat Med,2012
3. Novel targets in non-small cell lung cancer: ROS1 and RET fusions;JF Gainor;Oncologist,2013
4. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;JG Paez;Science,2004
5. Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond;SH Ou;Drug Des Devel Ther,2011
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献